🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
1.730
+0.050 (2.98%)
At close: Nov 20, 2026, 4:00 PM EST
1.740
+0.010 (0.58%)
After-hours: Nov 20, 2026, 7:30 PM EST

XBiotech Statistics

Total Valuation

XBiotech has a market cap or net worth of $52.74 million. The enterprise value is -$52.29 million.

Market Cap52.74M
Enterprise Value -52.29M

Important Dates

The last earnings date was Thursday, November 12, 2026.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

XBiotech has 30.49 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class 30.49M
Shares Outstanding 30.49M
Shares Change (YoY) +0.02%
Shares Change (QoQ) n/a
Owned by Insiders (%) 36.87%
Owned by Institutions (%) 6.57%
Float 19.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.41
P/TBV Ratio 0.44
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 39.51, with zero debt.

Current Ratio 39.51
Quick Ratio 39.12
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -29.94% and return on invested capital (ROIC) is -250.23%.

Return on Equity (ROE) -29.94%
Return on Assets (ROA) -19.72%
Return on Invested Capital (ROIC) -250.23%
Return on Capital Employed (ROCE) -37.72%
Weighted Average Cost of Capital (WACC) 8.35%
Revenue Per Employee n/a
Profits Per Employee -$500,977
Employee Count52
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, XBiotech has paid $206,000 in taxes.

Income Tax 206,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -19.91% in the last 52 weeks. The beta is 0.75, so XBiotech's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change -19.91%
50-Day Moving Average 2.04
200-Day Moving Average 2.27
Relative Strength Index (RSI) 33.96
Average Volume (20 Days) 81,077

Short Selling Information

The latest short interest is 315,307, so 1.03% of the outstanding shares have been sold short.

Short Interest 315,307
Short Previous Month 300,908
Short % of Shares Out 1.03%
Short % of Float 1.64%
Short Ratio (days to cover) 3.74

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -47.49M
Pretax Income -43.38M
Net Income -43.59M
EBITDA -46.23M
EBIT -47.49M
Earnings Per Share (EPS) -$1.43
Full Income Statement

Balance Sheet

The company has $105.04 million in cash and no debt, with a net cash position of $105.04 million or $3.45 per share.

Cash & Cash Equivalents 105.04M
Total Debt n/a
Net Cash 105.04M
Net Cash Per Share $3.45
Equity (Book Value) 124.07M
Book Value Per Share 4.07
Working Capital 103.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.96 million and capital expenditures -$46,000, giving a free cash flow of -$41.00 million.

Operating Cash Flow -40.96M
Capital Expenditures -46,000
Depreciation & Amortization 1.26M
Net Borrowing n/a
Free Cash Flow -41.00M
FCF Per Share -$1.34
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -0.02%
Shareholder Yield -0.02%
Earnings Yield -82.66%
FCF Yield -75.13%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1